z-logo
open-access-imgOpen Access
GDF11 induces mild hepatic fibrosis independent of metabolic health
Author(s) -
Jan Fröhlich,
Kristína Kovačovicová,
Tommaso Mazza,
Maria Rita Emma,
Daniela Cabibi,
Michelangelo Foti,
Cyril Sobolewski,
Jude A. Oben,
Marion Peyrou,
Francesc Villarroya,
Maurizio Soresi,
Rita Rezzani,
Melchiorre Cervello,
Francesca Bonomini,
Anna Alisi,
Manlio Vinciguerra
Publication year - 2020
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.104182
Subject(s) - steatohepatitis , steatosis , fatty liver , medicine , fibrosis , hepatic stellate cell , hepatic fibrosis , endocrinology , pathological , disease
Growth Differentiation Factor 11 (GDF11) is an anti-aging factor, yet its role in liver diseases is not established. We evaluated the role of GDF11 in healthy conditions and in the transition from non-alcoholic fatty liver disease (NAFLD) to non-alcoholic steatohepatitis (NASH).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom